Genprex S-1 IPO Lists on the NASDAQ — Gene Therapy Lung Cancer Treatment Gets Funded – Equities.com
Genprex S-1 IPO Lists on the NASDAQ — Gene Therapy Lung Cancer Treatment Gets FundedEquities.comGenprex has completed their S-1 IPO offering. Their IPO is now listed and trading on the Nasdaq Exchange under the ticker NASDAQ: GNPX. The offering raised… Continue reading
